Immunonutrition vs EPA-DHA enriched nutrition for cancer patients having surgery
Official title: IMMUNONUTRITION VS EPA-DHA ENRICHED NUTRITIONAL SUPPORT IN PATIENTS WITH CANCER UNDERGOING SURGERY
Run by Maimónides Biomedical Research Institute of Córdoba · NCT07860372 · Data updated 2026-11-12
This study tests whether immunonutrition or EPA-DHA enriched supplements improve outcomes for cancer patients undergoing surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Maimónides Biomedical Research Institute of Córdoba Academic / other |
| Locations | 1 site (Córdoba, Córdoba) |
| Status | Recruiting |
| Started | November 2, 2026 |
| Main results expected | November 2, 2027 |
| Study ends | November 2, 2028 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07860372 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with cancer undergoing surgery (gastrointestinal tract, ovarian, or peritoneal carcinomatosis) who can receive immunonutrition or EPA-DHA enriched supplements.
✕Probably not a fit
Patients with end-stage liver or kidney disease, or those unable to receive nutritional supplementation, may not derive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares two nutritional approaches given around cancer surgery: immunonutrition and EPA-DHA enriched oral supplements. It aims to observe clinical and molecular effects to see which strategy may better support patients through surgery. Participants are cancer patients undergoing surgical procedures in the gastrointestinal tract, ovaries, or with peritoneal spread, and are given one of the two nutritional regimens. Data collection focuses on post-surgical outcomes and molecular markers related to nutrition and recovery. Lead researchers are based at IMIBIC in Córdoba, Spain.
Why it matters
Potential benefit: If successful, the findings could help identify which nutritional approach offers better recovery and outcomes after cancer surgery.
How similar studies have gone: Related studies in perioperative nutrition have shown signals of benefit with immunonutrition or omega-3 enriched support, though direct head-to-head comparisons remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with cancer undergoing surgery (primary tumor location; gastrointestinal tract, ovarian, peritoneal carcinomatosis) Exclusion Criteria: * End-stage liver disease * End-stage kidney disease
Where it's running
-
Imibic
Córdoba, Córdoba, Spain Recruiting
Study contacts
- Study coordinator: Jose Carlos Garrido, PhD
- Email: josecarlos.garrido@imibic.org
- Phone: 957 736 571
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
International Childhood Leukemia Microbiome and Metabolome Cohort
This study is trying to see how nutrition affects treatment and recovery in children aged 3 to 18 who have just been diagnosed with acute lymphoblastic leukemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.